Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome-Reference-Cited by-同舟云学术

Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome

Published:2020-02-19 Issue:2 Volume:373 Page:193-203
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Hargrove Diane M.,Alagarsamy Sudarkodi,Croston Glenn,Laporte Régent,Qi Steve,Srinivasan Karthik,Sueiras-Diaz Javier,Wiśniewski Kazimierz,Hartwig Jennifer,Lu Mark,Posch Alexander P.,Wiśniewska Halina,Schteingart Claudio D.,Rivière Pierre J.-M.,Dimitriadou Violetta

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference51 articles.

1. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2

2. GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model

3. The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant–antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D

4. Modulation of specific intestinal epithelial progenitors by enteric neurons

5. Teduglutide in Crohn's disease

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the GLP-2 receptor in the management of obesity;Peptides;2024-07

2. Chronic Intestinal Failure and Short Bowel Syndrome in Adults: The State of the Art;GE - Portuguese Journal of Gastroenterology;2024-05-23

3. Pharmacokinetics and Tolerability of a Single Dose of Apraglutide, a Novel, Long‐Acting, Synthetic glucagon‐like peptide‐2 Analog With a Unique Pharmacologic Profile, in Individuals With Impaired Renal Function;The Journal of Clinical Pharmacology;2024-03-11

4. GLP-2 regulation of intestinal lipid handling;Frontiers in Physiology;2024-02-14

5. Clinical challenges of short bowel syndrome and the path forward for organoid-based regenerative medicine;Regenerative Therapy;2023-12